Summary
12.72 0.23(1.80%)04/29/2025
Avantor, Inc. (AVTR)
AVTR reported last earnings on 2025-04-25 after the market. An EPS of $0.23 was observed compared to an estimated EPS of $0.23, resulting in a surprise value of $0.00. A revenue of $1,581 million was observed compared to an estimated revenue of $1,671 million, resulting in a surprise value of $-89 Million.
Avantor, Inc. (AVTR)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 1.80 | -18.26 | -22.81 | -44.32 | -44.83 | -48.13 | -15.03 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Fundamental Ratings
| Category | Rating |
| Main Rating | B+ |
| Recommended Rating | Neutral |
| DCF | Strong Buy |
| ROE | Strong Buy |
| ROA | Strong Buy |
| Debt/Equity | Sell |
| P/E | Strong Sell |
| P/B | Strong Sell |
Earnings
| Trading Data | ||
| Close | 12.72 | |
| Open | 12.41 | |
| High | 12.79 | |
| Low | 12.25 | |
| Volume | 11,608,491 | |
| Change | 0.23 | |
| Change % | 1.80 | |
| Avg Volume (20 Days) | 13,821,815 | |
| Volume/Avg Volume (20 Days) Ratio | 0.84 | |
| 52 Week Range | 12.92 - 28.00 | |
| Price vs 52 Week High | -54.59% | |
| Price vs 52 Week Low | -1.59% | |
| Range | 0.00 | |
| Gap Up/Down | -0.64 | |
Profitibility | ||
| Market Capitalization (Mln) | 10,334 | |
| Revenue per share | 7.4979 | |
| Net Income per share | 1.0513 | |
| Dividend Yield | 0.0000 | |
| Dividend Share | 0.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 11.8809 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
04/28 12:25 EST - zacks.com
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
04/28 09:28 EST - benzinga.com
Avantor Analysts Cut Their Forecasts After Q1 Results
Avantor Inc AVTR reported in-line earnings for its first quarter on Friday.
Avantor Analysts Cut Their Forecasts After Q1 Results
Avantor Inc AVTR reported in-line earnings for its first quarter on Friday.
04/26 05:01 EST - seekingalpha.com
Avantor: A Healthier Diagnosis As Expectations Cool
Avantor's shares have nearly halved since October, driven by lackluster organic growth, elevated debt, and a mixed financial track record. The company operates in two segments, generating nearly $7 billion in sales, with significant exposure to laboratory solutions and bioscience production....
Avantor: A Healthier Diagnosis As Expectations Cool
Avantor's shares have nearly halved since October, driven by lackluster organic growth, elevated debt, and a mixed financial track record. The company operates in two segments, generating nearly $7 billion in sales, with significant exposure to laboratory solutions and bioscience production....
04/25 12:24 EST - benzinga.com
Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift
Avantor Inc AVTR on Friday reported adjusted EPS of 23 cents in line with consensus.
Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift
Avantor Inc AVTR on Friday reported adjusted EPS of 23 cents in line with consensus.
04/25 11:11 EST - investopedia.com
Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut
Avantor (AVTR) shares sank 16% Friday after the maker of lab chemicals and other life sciences products announced its CEO was resigning, reported weaker-than-expected net sales as government spending fell, and slashed its guidance.
Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut
Avantor (AVTR) shares sank 16% Friday after the maker of lab chemicals and other life sciences products announced its CEO was resigning, reported weaker-than-expected net sales as government spending fell, and slashed its guidance.
04/25 10:53 EST - seekingalpha.com
Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR ) Q1 2025 Earnings Call April 25, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications and Brand Michael Stubblefield - President and CEO R. Brent Jones - EVP and CFO Conference Call Participants Michael Ryskin - Bank of America Securities Vijay...
Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR ) Q1 2025 Earnings Call April 25, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications and Brand Michael Stubblefield - President and CEO R. Brent Jones - EVP and CFO Conference Call Participants Michael Ryskin - Bank of America Securities Vijay...
04/25 10:35 EST - zacks.com
Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Avantor (AVTR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Avantor (AVTR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
04/25 08:15 EST - zacks.com
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.23 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago.
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.23 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago.
04/25 06:07 EST - prnewswire.com
Avantor® Announces CEO Transition
Board initiates search process to identify next CEO RADNOR, Pa. , April 25, 2025 /PRNewswire/ -- Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, today announced that Michael Stubblefield intends to step...
Avantor® Announces CEO Transition
Board initiates search process to identify next CEO RADNOR, Pa. , April 25, 2025 /PRNewswire/ -- Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, today announced that Michael Stubblefield intends to step...
04/25 06:05 EST - prnewswire.com
Avantor® Reports First Quarter 2025 Results
Net sales of $1.58 billion, decrease of 6%; organic decline of 2% Net income of $64.5 million; Adjusted EBITDA of $269.5 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.23 Operating cash flow of $109.3 million; free cash flow of $82.1 million Announces significant actions across the business...
Avantor® Reports First Quarter 2025 Results
Net sales of $1.58 billion, decrease of 6%; organic decline of 2% Net income of $64.5 million; Adjusted EBITDA of $269.5 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.23 Operating cash flow of $109.3 million; free cash flow of $82.1 million Announces significant actions across the business...
04/01 08:05 EST - prnewswire.com
Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX
Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa. , April 1, 2025 /PRNewswire/ -- Avantor®, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries,...
Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX
Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa. , April 1, 2025 /PRNewswire/ -- Avantor®, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries,...
03/28 08:05 EST - prnewswire.com
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025
RADNOR, Pa. , March 28, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2025 financial results before the...
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025
RADNOR, Pa. , March 28, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2025 financial results before the...
03/27 11:30 EST - zacks.com
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now
Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks.
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now
Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks.
03/17 07:05 EST - prnewswire.com
Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025
Facility in Gliwice, Poland to boost biopharma manufacturers' efficiency and speed to market of therapies RADNOR, Pa. , March 17, 2025 /PRNewswire/ --Â Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology...
Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025
Facility in Gliwice, Poland to boost biopharma manufacturers' efficiency and speed to market of therapies RADNOR, Pa. , March 17, 2025 /PRNewswire/ --Â Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology...
02/19 08:05 EST - prnewswire.com
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference
RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th...
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference
RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th...
02/19 08:03 EST - businesswire.com
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology
SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE: AVTR), and a leading global supplier of high-quality silicones for long-term medical implants,...
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology
SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE: AVTR), and a leading global supplier of high-quality silicones for long-term medical implants,...
02/10 12:46 EST - zacks.com
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.
02/07 11:08 EST - seekingalpha.com
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent Jones - EVP and CFO Conference Call Participants Vijay Kumar - Evercore ISI Michael Ryskin - Bank...
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent Jones - EVP and CFO Conference Call Participants Vijay Kumar - Evercore ISI Michael Ryskin - Bank...
02/07 10:31 EST - zacks.com
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
02/07 09:15 EST - benzinga.com
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion.
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion.